Target intelligence / Profile preview

Stool water content and intestinal lumen

Molecular classification
Other, Physiological parameter, Anatomical location
01

Overview

Stool water content refers to the proportion of water within fecal matter, which is a critical determinant of stool consistency and transit time through the intestinal lumen (Rose et al., 2015). The intestinal lumen is the internal space of the gastrointestinal tract where digestion, nutrient absorption, and waste processing occur (Hall & Hall, 2020). While "stool water content and intestinal lumen" is not a specific molecular target such as a protein or receptor, it represents a key physiological endpoint for various pharmacological interventions aimed at treating gastrointestinal disorders (Schiller, 2001). Drugs such as osmotic laxatives (e.g., polyethylene glycol) increase stool water content by creating an osmotic gradient that draws fluid into the lumen, whereas secretagogues like linaclotide activate epithelial receptors to stimulate fluid secretion (Lembo et al., 2011). Conversely, antidiarrheal agents like loperamide slow intestinal motility, allowing more time for the intestinal mucosa to reabsorb water from the lumen, thereby decreasing stool water content (Schiller, 2017). Maintaining the balance of fluid within the intestinal lumen is essential for normal bowel function, and its dysregulation is central to the pathophysiology of constipation and diarrhea (Rose et al., 2015).

Other names
Fecal water contentIntestinal luminal fluidStool consistencyFecal moisture
02

Mechanism of action

Pharmacological agents modulate stool water content by altering the osmotic pressure within the intestinal lumen, activating secretory pathways in the intestinal epithelium (e.g., GC-C or ClC-2 activation), or modifying gastrointestinal motility to influence the duration of water reabsorption.

03

Biological functions

OtherFluid homeostasisWaste excretionElectrolyte transportIntestinal transit
04

Disease associations

OtherConstipationDiarrheaIrritable bowel syndrome (IBS)Inflammatory bowel disease (IBD)
05

Safety considerations

Electrolyte disturbances (e.g., hypokalemia, hypermagnesemia)DehydrationAbdominal distension and crampingLaxative dependencyMalabsorption of nutrients or co-administered drugs
06

Interacting drugs

Polyethylene glycol

6 more in the full profile.

07

Biomarkers

Bristol Stool Form Scale (BSFS)Stool weightFecal water percentageColonic transit timeStool frequency

Beyond the preview

Go deeper on Stool water content and intestinal lumen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stool water content and intestinal lumen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call